About: Immunogenicity of induced pluripotent stem cells

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity of induced pluripotent stem cells Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2011 (uk) article scientifique publié en 2011 (fr) im September 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2011 (ast) scientific article published on 01 September 2011 (en)
publication date	wds:Q84949816-6C454920-3E0E-4F41-8FD4-C98A5479B4C2
publication date	2011-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q84949816-9CA4E02E-C17A-4B0B-8DCC-DC098DD1FCF0
language of work or name	English
cites work	wds:Q84949816-0B19A4F8-A8B3-4CD1-8726-E25CED1A216A wds:Q84949816-3D67B11B-2099-41A5-8C70-9AA1A4297BFF wds:Q84949816-61A9A1D1-C7E5-4D52-9B52-77353F08126A wds:Q84949816-692A170A-1446-479D-8559-58AC7AC03E28 wds:Q84949816-75B6C475-9F2C-4741-BDF3-77548F6B853C wds:Q84949816-C31C6C8A-5264-4AE9-A500-DDE553DA8A30 wds:Q84949816-C8A610B6-7175-49A1-A6EE-546897638FCB
cites work	Immunogenicity of induced pluripotent stem cells Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Marked differences in differentiation propensity among human embryonic stem cell lines Natural immunity to pluripotency antigen OCT4 in humans Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching
author name string	wds:Q84949816-CFC93EA9-57F6-468A-8CE2-825ECCDD3906
author name string	Naoki Nagata
rdfs:label	Immunogenicity of induced pluripotent stem cells (en) Immunogenicity of induced pluripotent stem cells (nl)
skos:prefLabel	Immunogenicity of induced pluripotent stem cells (en) Immunogenicity of induced pluripotent stem cells (nl)
name	Immunogenicity of induced pluripotent stem cells (en) Immunogenicity of induced pluripotent stem cells (nl)
author	wds:Q84949816-84FD20BA-0724-428B-8BC5-D2F3554919CF wds:Q84949816-AD1327E1-5395-4AA4-9F01-28FAB9038D92
author	Shinya Yamanaka Keisuke Okita
title	wds:Q84949816-ED40EBBF-6055-4634-B296-25E45227B7AE
title	Immunogenicity of induced pluripotent stem cells (en)
page(s)	wds:Q84949816-456BA2DD-835F-45BB-9484-58A958CAD06D
page(s)	720-721
instance of	wds:Q84949816-DCE45F71-900B-44E9-80A8-5DE2A580F0FA
instance of	scholarly article
PubMed ID	wds:Q84949816-C82093ED-A007-421E-9A6C-5D9325484974
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21921270
PubMed ID	21921270
published in	wds:Q84949816-FFC600C9-DE26-4831-9BBF-901038EEDE2D
published in	Circulation Research
issue	wds:Q84949816-D09C102F-8DD3-4A53-98C1-C26195B97F43
volume	wds:Q84949816-58CC1430-8B32-429E-8125-A938425439DA
issue	7
volume	109
DOI	wds:Q84949816-8173BF0A-7886-4E2C-949B-B1432A93687C
DOI	http://dx.doi.org/10.1161/RES.0B013E318232E187
DOI	10.1161/RES.0B013E318232E187
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q84949816
is cites work of	Induced pluripotent stem cells: past, present, and future Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor From "ES-like" cells to induced pluripotent stem cells: a historical perspective in domestic animals. Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells Naive-like conversion overcomes the limited differentiation capacity of induced pluripotent stem cells Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord Genetic and epigenetic variations in iPSCs: potential causes and implications for application Comparative study of immune regulatory properties of stem cells derived from different tissues To be immunogenic, or not to be: that's the iPSC question Using human induced pluripotent stem cells to treat retinal disease Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin iPS cell sheets created by a novel magnetite tissue engineering method for reparative angiogenesis Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair Methods of induced pluripotent stem cells for clinical application iPS cell technologies: significance and applications to CNS regeneration and disease Induced pluripotent stem cell (iPSCs) and their application in immunotherapy Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future Cell-based therapy for kidney disease Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies Endogenous cardiac stem cells for the treatment of heart failure Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells Two decades of embryonic stem cells: a historical overview hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine Overview: an iPS cell stock at CiRA Challenges for the Therapeutic use of Pluripotent Stem Derived Cells Adult-derived pluripotent stem cells Transflammation: Innate immune signaling in nuclear reprogramming Present and future challenges of induced pluripotent stem cells Therapeutic use of stem cells for cardiovascular disease No immunogenicity of IPS cells in syngeneic host studied by in vivo injection and 3D scaffold experiments Technology advancement for integrative stem cell analyses Perspectives of gene combinations in phenotype presentation Human umbilical mesenchymal stem cells conditioned medium promote primary wound healing regeneration. Developing Cell-Based Therapies for RPE-Associated Degenerative Eye Diseases

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software